BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19562704)

  • 1. Early high peak hepatitis C viral load levels independently predict hepatitis C-related liver failure post-liver transplantation.
    Shackel NA; Jamias J; Rahman W; Prakoso E; Strasser SI; Koorey DJ; Crawford MD; Verran DJ; Gallagher J; McCaughan GW
    Liver Transpl; 2009 Jul; 15(7):709-18. PubMed ID: 19562704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C.
    Ciccorossi P; Maina AM; Oliveri F; Petruccelli S; Leandro G; Colombatto P; Moriconi F; Mosca F; Filipponi F; Bonino F; Brunetto MR
    Liver Int; 2007 Jun; 27(5):612-9. PubMed ID: 17498245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scarce influence of corticosteroid boluses on long-term viral load and liver histology in transplanted patients with recurrent hepatitis C.
    Barcena R; Oton E; Barreales M; Castillo M; Blesa C
    Transplant Proc; 2006 Oct; 38(8):2502-4. PubMed ID: 17097981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
    Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors.
    Aloia TA; Knight R; Gaber AO; Ghobrial RM; Goss JA
    Liver Transpl; 2010 Aug; 16(8):950-9. PubMed ID: 20589647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation.
    Selzner M; Kashfi A; Selzner N; McCluskey S; Greig PD; Cattral MS; Levy GA; Lilly L; Renner EL; Therapondos G; Adcock LE; Grant DR; McGilvray ID
    Liver Transpl; 2009 Oct; 15(10):1288-95. PubMed ID: 19790152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
    Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
    Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
    Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
    Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L; Koepsell T; Manhart L; Ioannou G
    Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis.
    Berenguer M; Aguilera V; Prieto M; Ortiz C; Rodríguez M; Gentili F; Risalde B; Rubin A; Cañada R; Palau A; Rayón JM
    Liver Transpl; 2009 Jul; 15(7):738-46. PubMed ID: 19562707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12-year period with more than 100 patients.
    Wigg AJ; Gunson BK; Mutimer DJ
    Liver Transpl; 2005 Jan; 11(1):27-34. PubMed ID: 15690533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.